ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,842.63
1.12%
US Tech 100
20,080.40
0.00%
다우존스 지수
43,006.59
1.14%
Bitcoin
91,442.31
0.89%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Zymeworks Inc (ZYME) 시세

Zymeworks Inc

Zymeworks Inc (ZYME)

NASDAQ
13.18
0.00
(0.00%)
마감 06 3월 6:00AM
15분 지연
0.00
0.00
(0.00%)
시간외 거래: -
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
13.18
매수가
12.30
매도가
12.45
거래량
-
0.00 일간 변동폭 0.00
7.97 52주 범위 17.70
market_cap
907.806M
전일 종가
13.18
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
456,162
발행 주식
68,877,526
배당수익률
-
주가수익률
-7.64
주당순이익(EPS)
-1.72
매출
76.01M
순이익
-118.67M

Zymeworks Inc 정보

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiat... Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates. Its lead clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.zymeworks.com
본부
Wilmington, Delaware, USA
설립됨
-
Zymeworks Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker ZYME. The last closing price for Zymeworks was US$13.18. Over the last year, Zymeworks shares have traded in a share price range of US$ 7.97 to US$ 17.70.

Zymeworks currently has 68,877,526 shares in issue. The market capitalisation of Zymeworks is US$907.81 million. Zymeworks has a price to earnings ratio (PE ratio) of -7.64.

ZYME 최신 뉴스

추가 뉴스

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
11 시간 전
ZYME (0.00%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
11 시간 전
ZYME (0.00%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
12 시간 전
ZYME (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
12 시간 전
ZYME (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
18 2월 2025
ZYME (0.00%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.68-4.906204906213.8614.0712.466193013.0500361CS
4-1.81-12.074716477714.9915.2512.443985013.7428435CS
12-0.1-0.75301204819313.2816.506512.445616213.97199049CS
261.2710.663308144411.9117.711.3550637413.72982123CS
521.088.9256198347112.117.77.9759038211.4293849CS
1566.8106.58307216.3817.76.0156057009.86025666CS
2606.8106.58307216.3817.76.0156057009.86025666CS

ZYME - Frequently Asked Questions (FAQ)

What is the current Zymeworks share price?
The current share price of Zymeworks is US$ 13.18
How many Zymeworks shares are in issue?
Zymeworks has 68,877,526 shares in issue
What is the market cap of Zymeworks?
The market capitalisation of Zymeworks is USD 907.81M
What is the 1 year trading range for Zymeworks share price?
Zymeworks has traded in the range of US$ 7.97 to US$ 17.70 during the past year
What is the PE ratio of Zymeworks?
The price to earnings ratio of Zymeworks is -7.64
What is the cash to sales ratio of Zymeworks?
The cash to sales ratio of Zymeworks is 11.92
What is the reporting currency for Zymeworks?
Zymeworks reports financial results in USD
What is the latest annual turnover for Zymeworks?
The latest annual turnover of Zymeworks is USD 76.01M
What is the latest annual profit for Zymeworks?
The latest annual profit of Zymeworks is USD -118.67M
What is the registered address of Zymeworks?
The registered address for Zymeworks is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Zymeworks website address?
The website address for Zymeworks is www.zymeworks.com
Which industry sector does Zymeworks operate in?
Zymeworks operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 77.5761
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.21
(0.00%)
0
AACGATA Creativity Global
US$ 0.8244
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.03
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 77.5761
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.21
(0.00%)
0
AACGATA Creativity Global
US$ 0.8244
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.03
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 77.5761
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.21
(0.00%)
0
AACGATA Creativity Global
US$ 0.8244
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.03
(0.00%)
0

토론

전체 피드 보기
againstallodds againstallodds 5 분 전
No significant short positions uncovered

Paig social promo clowns trying to use that old trick

No uncovered = No short squeeze

From OTC

https://investorshub.advfn.com/uimage/uploads/2025/3/6/rcmnhIMG_0326.jpeg
NBRI
havnagoodtime havnagoodtime 8 분 전
You could request a review, if you want.
HMBL
sam1933 sam1933 11 분 전
Neuron Goes Live on Hedera to Prevent Aerial Disasters
[pre]After a tragic plane-helicopter collision killed 67,
aviation safety is in focus.[/pre]

https://www.altcoinbuzz.io/cryptocurrency-news/neuron-goes-live-on-hedera-to-prevent-aerial-disasters/
HBARUSD
sam1933 sam1933 17 분 전
Hedera: A Fit For All Narratives
https://i.redd.it/phvz36igctce1.jpeg
HBARUSD
Seminole Red Seminole Red 21 분 전
you guys put up some good ones always.
Seminole Red Seminole Red 25 분 전
sure are alot of WD's this week
pgsd pgsd 34 분 전
As the report in your link clearly shows .....NOT

“We are starting to make progress. We now have a few syngenic, clinically relevant mouse models, but we don’t still have the richness of, say, breast or lung cancer, where there are hundreds of relevant models.”

"Mouse
NWBO
Toofuzzy Toofuzzy 41 분 전
With the turmoil in the market I decided to review all my holdings for AIM directed trades.

I sold WPM and because of option selling will have to wait till next January to sell more. Most options have a $75 strike.

I decided to close out trading on EFA. AIM has hardly g
Investor082 Investor082 41 분 전
She will release fluff PRs such as Oncovir partnership and likely news on combo trials but none of that will move the stock, just like Roswell Park announcement. In fact, any PR that does not involve significant non dilutive cash will ultimately result in sell the news scenario. Only news that matte
NWBO
DesktopDR DesktopDR 49 분 전
Class Action Lawsuits topped 40 Billion again in 2024. If the right media covers this, VPLM's stock price will soar!
https://www.forbes.com/sites/edwardsegal/2025/01/07/class-action-settlements-topped-40-billion-again-in-2024-new-report/
VPLM
HoldEm777 HoldEm777 49 분 전
That’s a “hundo” each trip up now for a month. That’s a solid tip you think?
https://investorshub.advfn.com/uimage/uploads/2025/3/6/ip[quIMG_7898.png
GTVH
RDY2ROCK RDY2ROCK 50 분 전
https://www.binance.com/en/square/post/19247288481466
The 2025 NFT Outlook

Even if the market is down, the technology and ideas behind it are still significant, and experts are forecasting that the industry will mature beyond its early excitement.

One potential r
PSRU
Big Momma Big Momma 52 분 전
If so confident, why so focused on what others are doing?

investorshub.advfn.com/uimage/uploads/2014/11/19/koxivYoda.jpg
HLLK
Toofuzzy Toofuzzy 59 분 전
Re: options with AIM

I use options three different ways.

1) I sell options equal to the amount I would sell.

If I own 1000 shares I might sell one option at the next trade price ( put or call ). Ideally the option premium takes me to the second trade pric
Toofuzzy Toofuzzy 59 분 전
Re: options with AIM

I use options three different ways.

1) I sell options equal to the amount I would sell.

If I own 1000 shares I might sell one option at the next trade price ( put or call ). Ideally the option premium takes me to the second trade pric
RDY2ROCK RDY2ROCK 1 시간 전
No BELR RS on the Horizon. Last split was 1:100 OCT 2017.
https://otce.finra.org/otce/dailyList?viewType=Dividends%2FDistributions%2FSplits
Which also shows on the OTC site:
https://www.otcmarkets.com/stock/BELR/security
AS = 5B & OS = 421,952,476 on 5 MAR 2025
BELR
NotSure2 NotSure2 1 시간 전
What happen to your "confirm info" that was ckearly wrong? You are just going to say "this week" everyweek?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175849282

Fireman/Smitty did u hacked into dbing account?
NWBO
LovePennyStock LovePennyStock 1 시간 전
The next major resistance is $1.72. If we break that , then I believe the share price will go much much higher to a new range between $4-$9. I'm ready to sell my first portion at $4. If anyone can post a screenshot of the Level2 of QMMM, I'd be really appreciated. Let's rock and roll !!!!!!!!
QMMM
cojoboy cojoboy 1 시간 전
Looks like my 73's look like chit..come on peeps..you attack for good buys..attack me for bad ones..😎😎😎😎😎
IGPK
Toofuzzy Toofuzzy 1 시간 전
Hi Tom

Looks like I had another precious metal sale ( wpm ) this month also. ( More in another post )

This will have to be my last sale till the end of January as I laddered calls against my shares at $65, $70, $75 in January just before the recent runup. Most were a $7
littlejohn littlejohn 1 시간 전
Grrr six month financials looked odd to

me back in summer of 2024...

Up to an auditor to determine how

they are navigating EGP value Plunge...

EGP value dropped over 30% about

a year ago on 03/04/2024...

EGP va
marcis marcis 2 시간 전
Every stock has like a three wave run

We haven’t seen wave one yet


He doesn’t realize scared money loses money

The rest of us that’s been trading years knows out of maybe twelve stocks in a portfolio we really only need one to make it big
RDAR
dirkv dirkv 2 시간 전
Vergnet : time for a strong recovery
Euronext Growth Paris FR001400JXA2

today: 1,123,324,208 x 0.0004 = 449.329 euro.
01/15/2025 0.0032 x 430.467.065 = 1.377.494 euro
12/10/2024 0.0064
11/01/2024 0.0083
10/03/2024 0.0329
09/05/2024 0.064
dirkv dirkv 2 시간 전
Vergnet : time for a strong recovery
Euronext Growth Paris FR001400JXA2

today: 1,123,324,208 x 0.0004 = 449.329 euro.
01/15/2025 0.0032 x 430.467.065 = 1.377.494 euro
12/10/2024 0.0064
11/01/2024 0.0083
10/03/2024 0.0329
09/05/2024 0.064

최근 히스토리

NASDAQ
ZYME
Zymeworks
BIT
1VIV
Vivendi
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지